Thyrocare Technologies Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

52.99

52.95

52.93

52.90

52.87

Share application money

-

-

4.51

3.43

2.93

Preference share capital

-

-

-

-

-

Reserves & surplus

484.11

460.86

463.60

464.37

389.66

Loan funds

Secured loans

-

19.77

-

-

-

Unsecured loans

-

-

-

-

-

Total

537.10

533.58

521.04

520.70

445.46

Uses of funds

Fixed assets

Gross block

338.52

284.67

264.69

236.95

191.48

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

180.97

125.38

108.02

87.56

72.33

Net block

157.55

159.29

156.67

149.39

119.15

Capital work-in-progress

14.17

0.76

0.82

2.15

8.28

Investments

283.80

291.46

273.94

259.39

273.81

Net current assets

Current assets, loans & advances

220.83

168.76

180.44

186.24

126.55

Less : current liabilities & provisions

139.25

86.69

90.83

76.47

82.33

Total net current assets

81.58

82.07

89.61

109.77

44.22

Miscellaneous expenses not written

-

-

-

-

-

Total

537.10

533.58

521.04

520.70

445.46

Notes:

Book value of unquoted investments

-

-

172.75

150.34

-

Market value of quoted investments

103.97

115.26

101.19

89.05

103.47

Contingent liabilities

216.39

299.65

-

-

129.05

Number of equity sharesoutstanding (Lacs)

529.93

529.53

529.30

529.03

528.74